Phenothiazines (drug interactions)

  • DEFINITION: Drugs used to treat schizophrenia and other forms of psychosis.
  • INTERACTIONS: Belladonna, coenzyme Q10, milk thistle, fish oil, ginkgo, vitamin E, vitamin B6, DHEA, glycine, jimsonweed, phenylalanine, kava, St. John’s wort, valerian root, yohimbe, prescription medications, alcohol, caffeine
  • DRUGS IN THIS FAMILY: Chlorpromazine hydrochloride (Thorazine), fluphenazine (Permitil, Prolixin), perphenazine (Trilafon), prochlorperazine (Compazine), promazine hydrochloride (Sparine), promethazine hydrochloride (injectable, Phenergan)

Coenzyme Q10 (CoQ10)

Effect: Supplementation Possibly Helpful

94416177-90738.jpg94416177-90739.jpg

Preliminary studies suggest that phenothiazine drugs might deplete the body of CoQ10. While there is no evidence that taking CoQ10 supplements provides any specific benefit, supplementing with CoQ10 might be a good idea if one is also taking phenothiazine drugs.

Fish Oil

Effect: Possible Helpful Interaction

Fish oil contains essential fatty acids in the omega-3 family. Its constituents, including a slightly modified fish oil constituent called ethyl eicosapentaenoic acid (ethyl-EPA), have all been tested for depression treatment. Incomplete and inconsistent evidence suggests that these substances might augment the effectiveness of standard medications used for schizophrenia.

Milk Thistle

Effect: Possible Helpful Interaction

Milk thistle might protect against the liver toxicity sometimes caused by phenothiazine drugs.

Ginkgo

Effect: Possible Helpful Interaction

Preliminary evidence suggests that ginkgo might reduce the side effects and increase the efficacy of various antipsychotic medications.

Vitamin E

Effect: Possible Helpful Interaction

One of the most feared side effects of phenothiazines is the development of a permanent side effect called tardive dyskinesia (TD). This late-developing (tardy, or tardive) complication consists of annoying uncontrollable movements (dyskinesias), particularly in the face.

In early studies, vitamin E had shown some promise for treating tardive dyskinesia, but the largest and best-designed study failed to find benefit.

Vitamin B6

Effect: Possible Helpful Interaction

A pilot study suggests that vitamin B6 may be helpful for the treatment of tardive dyskinesia (TD). In this four-week, double-blind crossover trial of fifteen persons, treatment with vitamin B6 significantly improved TD symptoms compared with placebo. Benefits were seen after one week of treatment. However, the dosage of vitamin B6 used in this study was quite high (400 mg daily). Toxicity has been reported with daily intake of vitamin B6 at one-half this dose. Vitamin B6 might also reduce symptoms of akathisia, a type of restlessness associated with phenothiazine antipsychotics.

Dehydroepiandrosterone (DHEA)

Effect: Possible Helpful Interaction

One small, double-blind study found that the use of DHEA reduced the Parkinson-like movement disorders that may occur in people taking phenothiazine drugs.

Glycine

Effect: Possible Helpful Interaction

Phenothiazine drugs are most effective for the “positive” symptoms of schizophrenia, such as hallucinations and delusions. (Such symptoms are called “positive” because they indicate the presence of abnormal mental functions rather than the absence of normal mental functions.) In general, however, these medications are less helpful for the “negative” symptoms of schizophrenia, such as apathy, depression, and social withdrawal. Some evidence hints that the supplement glycine might enhance the effectiveness of phenothiazines in relation to this latter class of symptoms.

Phenylalanine

Effect: Possible Increased Risk of Tardive Dyskinesia

There are some indications that using the supplement phenylalanine while taking antipsychotic drugs might increase one’s risk of developing tardive dyskinesia.

Kava

Effect: Possible Increased Risk of Dystonic Reactions

Besides the late-developing complication of tardive dyskinesia, antipsychotic drugs can cause another movement disorder: dystonic reactions (sudden intense movements of the neck and eyes). There is some evidence that the herb kava can increase the risk or severity of this side effect.

St. John’s Wort, Other Herbs

Effect: Potential Increased Risk of Photosensitivity

Phenothiazines can cause increased sensitivity to the sun. Various herbs, including St. John’s wort and dong quai, can also cause this problem. Combined treatment with these herbs and phenothiazines might increase the risk further.

Yohimbe

Effect: Possible Dangerous Interaction

The herb yohimbe is relatively toxic and can cause problems if used incorrectly. Phenothiazine medications may increase the risk of toxicity.

Other Interactions

Several additional herbs and supplements may offer positive and negative effects when taken with phenothiazines. For example, valerian root, known for its sedative properties, may cause dangerous levels of sedation when combined with phenothiazines. Herbs with anticholinergic effects, such as belladonna and jimsonweed, should also be avoided when taking phenothiazines. There is a long list of medications that interact with phenothiazine, ranging from minor to major interactions. Patients are encouraged to discuss all prescription medications with their healthcare provider before taking phenothiazine. Prescription medications that should be avoided include anticholinergic medications, antihypertensive medications, and medications for Parkinson's disease. Further, patients suffering from numerous conditions, such as certain cancers, heart disease, and lung, kidney, or brain disorders, should avoid taking phenothiazine due to potential medication interactions. Alcohol should be avoided when taking phenothiazine, as it may cause excess central nervous system depression and increase sedation to dangerous levels. Caffeine may make phenothiazines less effective.

Bibliography

Berger, G. E., et al. "Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis." Journal of Clinical Psychiatry, vol. 68, 2007, pp. 1867-1875.

Emsley, R., et al. "Randomized, Placebo-Controlled Study of Ethyl-Eicosapentaenoic Acid as Supplemental Treatment in Schizophrenia." American Journal of Psychiatry, vol. 159, 2002, pp. 1596-1598.

Fenton, W. S., et al. "A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia." American Journal of Psychiatry, vol. 158, 2001, pp. 2071-2074.

Kidron, Ariel, and Hoang Nguyen. "Phenothiazine - StatPearls." NCBI, 23 May 2023, www.ncbi.nlm.nih.gov/books/NBK556113. Accessed 7 Oct. 2024.

Lerner, V., et al. "Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia." Journal of Clinical Psychiatry, vol. 65, 2004, pp. 1550-1554.

Nachshoni, T., et al. "Improvement of Extrapyramidal Symptoms Following Dehydroepiandrosterone (DHEA) Administration in Antipsychotic Treated Schizophrenia Patients." Schizophrenia Research, vol. 79, nos. 2/3, 2005, pp. 251-256.

Peet, M. "Eicosapentaenoic Acid in the Treatment of Schizophrenia and Depression: Rationale and Preliminary Double-Blind Clinical Trial Results." Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 69, 2003, pp. 477-485.

"Phenothiazine (Oral Route, Parenteral Route, Rectal Route)." Mayo Clinic, 1 Feb. 2024, www.mayoclinic.org/drugs-supplements/phenothiazine-oral-route-parenteral-route-rectal-route/precautions/drg-20070394. Accessed 7 Oct. 2024.

Zhang, X. Y., et al. "A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients with Schizophrenia." Journal of Clinical Psychiatry, vol. 62, 2001, pp. 878-883.